Radiation dose reduction by adjusting bolus tracking parameters in a 320-detector row scanner

Jacqueline Kioko Nishimura Matsumoto1, Antonildes Nascimento Assuncao-Jr1, Roberto Nery Dantas Junior1

  • 1Computed Tomography Department, Heart Institute (InCor), University of Sao Paulo Medical School, Brazil.

Insights

Optimizing bolus tracking (BT) parameters in coronary computed tomography angiography (CTA) significantly reduces effective radiation dose (ERD). Adjusting BT protocols lowers radiation exposure without compromising diagnostic image quality.

Area of Science:

  • Radiology
  • Medical Imaging
  • Radiation Dose Reduction

Background:

  • Bolus tracking (BT) is crucial for optimizing contrast delivery in coronary computed tomography angiography (CTA).
  • The impact of BT parameter optimization on total effective radiation dose (ERD) in CTA has been under-explored.
  • Reducing ERD is a key objective in modern medical imaging.

Purpose of the Study:

  • To investigate whether adjusting BT parameters can effectively reduce ERD in CTA.
  • To evaluate the impact of different BT delay and intermittent scan timings on radiation dose.
  • To assess if dose reduction affects image quality.

Main Methods:

  • 289 adult patients undergoing CTA were allocated to four BT protocols with varying delay and intermittent scan times.
  • Protocols differed in delay (10s vs. 15s) and intermittent scan frequency (1s vs. 2s).
  • Image quality and total ERD were assessed for each protocol.

Main Results:

  • Overall ERD in BT was significantly lower than in standard acquisition (0.32 ± 0.14 mSv vs. 6.06 ± 0.66 mSv).
  • ERD varied significantly across BT protocols (p < 0.001), with protocol D (15s delay, 2s intermittent scans) showing the lowest dose (0.23 ± 0.09 mSv).
  • Protocol D demonstrated the highest reduction in ERD (β = -0.33, p = 0.004) without compromising image quality.

Conclusions:

  • Adjusting bolus tracking parameters by increasing delay time and decreasing scan frequency reduces radiation dose in CTA.
  • Optimized BT protocols significantly lower ERD compared to standard methods.
  • Radiation dose reduction is achievable without sacrificing diagnostic image quality in CTA.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
492
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
18.1K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
231
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
261